Literature DB >> 24510697

Reactive arthritis induced by intravesical BCG therapy for bladder cancer.

Kaouther Ben Abdelghani1, Alia Fazaa, Leila Souabni, Leith Zakraoui.   

Abstract

Cancers of the bladder could be treated with intravesical instillation of BCG therapy. This treatment could lead to some complications. Osteoarticular ones are relatively uncommon. We describe an original observation, illustrating the development of reactive arthritis after intravesical BCG therapy. A 60-year-old man was followed for a T1G3 transitional papillary carcinoma of the bladder and was treated with intravesical BCG immunotherapy. Within the sixth intravesical instillation, he presented with polyarthritis confirmed by musculoskeletal ultrasound. The erythrocyte sedimentation rate was 100 mm without leukocytosis. The viral and bacterial serologies and immunological tests were negative. The ophthalmological examination revealed left conjunctivitis. Treatment with non-steroidal anti-inflammatory drugs was started, combined with the discontinuation of the intravesical instillation. No recurrence has been reported with a current decline of 2 years.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24510697      PMCID: PMC3918606          DOI: 10.1136/bcr-2013-202741

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  [Evaluation of tolerance to endovesical BCG treatment in France: analysis of severe adverse effects notified in 3 years].

Authors:  H Debois; E Loupi; P Saliou; H Blangy; D Loeuille; P Gillet
Journal:  Prog Urol       Date:  2001-06       Impact factor: 0.915

2.  Response to treatment with tocilizumab of reactive arthritis induced by intravesical bacillus Galmette-Guérin unresponsive to DMARDs.

Authors:  Kevin Kwan; Sneha Bharadwaj; Charles Inderjeeth
Journal:  Int J Rheum Dis       Date:  2012-04-29       Impact factor: 2.454

3.  Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

Authors:  Toshio Tanaka; Yusuke Kuwahara; Yoshihito Shima; Toru Hirano; Mari Kawai; Masako Ogawa; Junsuke Arimitsu; Keisuke Hagihara; Masashi Narazaki; Atsushi Ogata; Ichiro Kawase; Tadamitsu Kishimoto
Journal:  Arthritis Rheum       Date:  2009-12-15

4.  Remitting seronegative symmetrical synovitis with pitting edema following intravesical bacillus Calmette-Guérin instillation.

Authors:  S Mouly; F Berenbaum; G Kaplan
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

5.  Remitting seronegative symmetrical synovitis pitting oedema after BCG instillation.

Authors:  Soumaya El Mahou; Luciana Popa; Arnaud Constantin; Alain Cantagrel; Achour Aberrane; Benedicte Jamard; Bernard Mazieres; Michel Laroche
Journal:  Clin Rheumatol       Date:  2006-03-25       Impact factor: 2.980

Review 6.  Reactive arthritis.

Authors:  Timo Hannu
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-06       Impact factor: 4.098

Review 7.  [Classification, favorable characteristics, prevention and treatment of adverse side-effects associated with Bacillus Calmette-Guerin in the treatment of superficial bladder cancer].

Authors:  F Saint; L Salomon; R Quintela; A Cicco; C C Abbou; D K Chopin
Journal:  Ann Urol (Paris)       Date:  2002-03

Review 8.  Osteoarthritis of the foot: a review of the current state of knowledge.

Authors:  Annamaria Iagnocco; Chiara Rizzo; Angelica Gattamelata; Caterina Vavala; Fulvia Ceccarelli; Elena Cravotto; Guido Valesini
Journal:  Med Ultrason       Date:  2013-03       Impact factor: 1.611

9.  Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer.

Authors:  D L Lamm; V D Stogdill; B J Stogdill; R G Crispen
Journal:  J Urol       Date:  1986-02       Impact factor: 7.450

10.  15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach.

Authors:  Chi Wai Cheng; Siu Foon Peter Chan; Lung Wai Chan; Chi Kwok Chan; Chi Fai Ng; Ho Yuen Cheung; Shu Yin Eddie Chan; Wai Sang Wong; Fernand Mac-Moune Lai; Miu Ling Li
Journal:  Jpn J Clin Oncol       Date:  2004-04       Impact factor: 3.019

View more
  5 in total

1.  Case: Bacillus Calmette-Guerin (BCG)-induced Reiter syndrome with an attempt at repeat BCG induction.

Authors:  Douglas C Cheung; Alexandra L Millman; Robert J Hamilton
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

2.  Ultrasonographic findings in a patient with reactive arthritis induced by intravesical BCG therapy for bladder cancer.

Authors:  Hitoshi Yoshimura; Tadashi Okano; Kentaro Inui; Hiroaki Nakamura
Journal:  J Med Ultrason (2001)       Date:  2018-07-10       Impact factor: 1.314

3.  Reactive arthritis induced by active extra-articular tuberculosis: A case report.

Authors:  Yushiro Endo; Shin-Ya Kawashiri; Tomohiro Koga; Momoko Okamoto; Sosuke Tsuji; Ayuko Takatani; Toshimasa Shimizu; Remi Sumiyoshi; Takashi Igawa; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

Review 4.  Managing the adverse events of intravesical bacillus Calmette-Guérin therapy.

Authors:  Karel Decaestecker; Willem Oosterlinck
Journal:  Res Rep Urol       Date:  2015-10-23

5.  Reactive Arthritis - A Rare Complication of Intravesical BCG Instillation.

Authors:  Marta Freixa; Sara Úria; Glória Nunes da Silva
Journal:  Eur J Case Rep Intern Med       Date:  2020-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.